Sept 30 Regeneron Pharmaceuticals Inc :
* Formulated with rinucumab (anti-PDGFR-beta) shows no benefit over aflibercept alone in neovascular age-related macular degeneration
* Combination therapy did not demonstrate improvement in BCVA versus intravitreal aflibercept injection monotherapy at 12 weeks
* Adding rinucumab to aflibercept showed no benefit on anatomic endpoints Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.